Travere Therapeutics Inc (TVTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2014 | 06-2014 | 03-2014 | 12-2013 | 09-2013 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -81,911 | -63,931 | -75,736 | -34,625 | -20,689 |
| Depreciation Amortization | 4,114 | 1,753 | 127 | 216 | 159 |
| Income taxes - deferred | N/A | N/A | 65 | 76 | N/A |
| Accounts receivable | -4,676 | -1,601 | -29 | N/A | 0 |
| Accounts payable and accrued liabilities | 13,764 | 6,546 | 1,577 | 2,842 | -313 |
| Other Working Capital | 7,681 | 4,152 | 2,012 | 1,493 | 919 |
| Other Operating Activity | 24,273 | 31,826 | 62,177 | 12,409 | 10,482 |
| Operating Cash Flow | $-36,755 | $-21,255 | $-9,806 | $-17,589 | $-9,442 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -7,990 | -3,047 | -1,065 | -1,145 | -6,643 |
| PPE Investments | -581 | -424 | -166 | -117 | -22 |
| Net Acquisitions | -29,150 | -29,150 | -29,150 | N/A | N/A |
| Purchase Of Investment | -400 | -400 | N/A | N/A | N/A |
| Sale Of Investment | 2,190 | -848 | -671 | 1,329 | N/A |
| Purchase Sale Intangibles | -3,302 | -3,301 | -61 | -5,433 | -6 |
| Other Investing Activity | -3,302 | -3,301 | -61 | -5,473 | -6 |
| Investing Cash Flow | $-39,233 | $-37,170 | $-31,113 | $-5,406 | $-6,670 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 85,290 | 80,676 | N/A | N/A | N/A |
| Debt Repayment | -31,283 | -31,283 | N/A | N/A | N/A |
| Common Stock Issued | 45,172 | 45,172 | 44,039 | 30,937 | 31,356 |
| Common Stock Repurchased | -2,257 | -2,257 | -2,257 | -958 | 0 |
| Other Financing Activity | -1,069 | 0 | -3,165 | -998 | -1,844 |
| Financing Cash Flow | $95,853 | $92,308 | $38,617 | $28,981 | $29,511 |
| Beginning Cash Position | 5,997 | 5,997 | 5,997 | 11 | 11 |
| End Cash Position | 25,862 | 39,880 | 3,696 | 5,997 | 13,410 |
| Net Cash Flow | $19,865 | $33,883 | $-2,302 | $5,986 | $13,398 |
| Free Cash Flow | |||||
| Operating Cash Flow | -36,755 | -21,255 | -9,806 | -17,589 | -9,442 |
| Capital Expenditure | -581 | -424 | -166 | -117 | -22 |
| Free Cash Flow | -37,336 | -21,679 | -9,972 | -17,706 | -9,465 |